HC-258
Product Specifications
Target
TEAD
Applications
Hippo
Additionnal Information
HC-258 is a covalent acrylamide inhibitor of TEAD that reduces the CTGF, CYR61, AXL, and NF2 transcript levels and inhibits the migration of MDA-MB-231 breast cancer cells.
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7032385-01 0.02 mg
Recombinant Saccharomyces cerevisiae Golgi apparatus membrane protein TVP18 (TVP18)
Sign In for Pricing
View Details MBS7032385-02 0.1 mg
Recombinant Saccharomyces cerevisiae Golgi apparatus membrane protein TVP18 (TVP18)
Sign In for Pricing
View Details MBS7032385-03 5x 0.1 mg
Recombinant Saccharomyces cerevisiae Golgi apparatus membrane protein TVP18 (TVP18)
Sign In for Pricing
View Details 
035156-ML490 100 µL
Erbb2, ID (Erbb2, Kiaa3023, Neu, Receptor tyrosine-protein kinase erbB-2, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, p185erbB2, CD340) (MaxLight 490) discontinued
Sign In for Pricing
View Details ARP79028_P050 100 µL
FILIP1 Antibody - N-terminal region (ARP79028_P050)
Sign In for Pricing
View Details 